Scientists suggest understanding ecDNA’s role in pancreatic cancer could potentially guide future strategies for making ...

Assembling DNA nanostructures at more moderate temperatures opens up the possibility of using the structures in biomedical applications.

The Breez 2 mL micro-bioreactor platform is a fully automated, functionally closed, and continuous perfusion cell culture ...

Roche and Zealand reason petrelintide could deliver weight loss comparable to glucagon-like peptide 1 (GLP-1) receptor ...

Rentosertib is designed to treat IPF by targeting Traf2- and NCK-interacting kinase (TNIK), a serine/threonine kinase whose activation plays a crucial role in cellular processes that include signal ...

The team was able to reach protein yields at the pool stage that couldn’t be achieved previously with a random integration approach.

A comprehensive atlas maps DNA methylation across 39 human cell types, revealing a complex landscape of epigenetic regulation.

Turning silver nanoparticles into commercial products could create a faster pathway to new antimicrobials and cancer treatments.

“When scaling up a process based on adherent cells, a biopharmaceutical manufacturer has two options. Either stay in 2D, resulting in the use of heavy and difficult-to-handle multi-tray stacks with a ...

Artificial intelligence (AI) and the Internet of Things (IoT) are about to revolutionize the biopharmaceutical industry.

The cell-based product is a nicotinamide modified allogeneic hematopoietic progenitor cell therapy that was FDA-OK'd and launched in 2023.

Lonza will leverage its expertise in exosome development and analytical services to define a GMP-compliant process for Exo-101 production.